Volterra Technologies LP Makes New $1.95 Million Investment in iShares Biotechnology ETF $IBB

Volterra Technologies LP acquired a new position in shares of iShares Biotechnology ETF (NASDAQ:IBB) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 13,495 shares of the financial services provider’s stock, valued at approximately $1,948,000. iShares Biotechnology ETF accounts for approximately 0.2% of Volterra Technologies LP’s portfolio, making the stock its 26th biggest position.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Darwin Wealth Management LLC purchased a new stake in shares of iShares Biotechnology ETF during the 2nd quarter worth approximately $25,000. Financial Gravity Companies Inc. acquired a new position in shares of iShares Biotechnology ETF during the second quarter worth about $29,000. Ashton Thomas Securities LLC acquired a new stake in shares of iShares Biotechnology ETF in the 3rd quarter valued at approximately $36,000. Bronte Capital Management Pty Ltd. raised its position in iShares Biotechnology ETF by 12.6% in the second quarter. Bronte Capital Management Pty Ltd. now owns 295,346 shares of the financial services provider’s stock worth $37,000 after acquiring an additional 32,947 shares in the last quarter. Finally, Parkside Financial Bank & Trust lifted its holdings in iShares Biotechnology ETF by 48.6% in the third quarter. Parkside Financial Bank & Trust now owns 266 shares of the financial services provider’s stock valued at $38,000 after acquiring an additional 87 shares during the period. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Performance

Shares of NASDAQ IBB opened at $165.51 on Friday. iShares Biotechnology ETF has a one year low of $107.43 and a one year high of $179.64. The company’s fifty day moving average is $172.69 and its two-hundred day moving average is $162.38.

iShares Biotechnology ETF Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Friday, December 19th. Shareholders of record on Tuesday, December 16th were given a dividend of $0.1831 per share. The ex-dividend date was Tuesday, December 16th. This is an increase from iShares Biotechnology ETF’s previous quarterly dividend of $0.08. This represents a $0.73 annualized dividend and a yield of 0.4%.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.